We are live on ! Find out more
HUMA icon

Humacyte
HUMA

23 hedge funds and large institutions have $26.2M invested in Humacyte in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, 3 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

10% more funds holding

Funds holding: 21 → 23 (+2)

19.27% less ownership

Funds ownership: 42.59% → 23.31% (-19%)

42% less capital invested

Capital invested by funds: $44.7M → $26.2M (-$18.6M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
–
Reduced
3
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AGM
Alpine Global Management
New York
+$5.69M
2
MS
Maven Securities
Jersey
+$5.58M
3
UOC
UBS O'Connor
Illinois
+$3.32M
4
EP
Eversept Partners
New York
+$2.61M
5
Millennium Management
Millennium Management
New York
+$508K

Top Sellers

1
OP
Omni Partners
United Kingdom
-$11M
2
BFM
Boothbay Fund Management
New York
-$6.2M
3
PC
Periscope Capital
Ontario, Canada
-$4.58M
4
AA
AQR Arbitrage
Connecticut
-$3.01M
5
MP
Mangrove Partners
Connecticut
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
Tudor Investment Corp
1
Tudor Investment Corp
Connecticut
$5.88M – – –
AGM
2
Alpine Global Management
New York
$5.64M +$5.69M +521,155 New
MS
3
Maven Securities
Jersey
$5.54M +$5.58M +511,400 New
UOC
4
UBS O'Connor
Illinois
$3.29M +$3.32M +303,800 New
EP
5
Eversept Partners
New York
$2.59M +$2.61M +239,026 New
Millennium Management
6
Millennium Management
New York
$504K +$508K +46,511 New
Marshall Wace
7
Marshall Wace
United Kingdom
$494K +$498K +45,590 New
WRBC
8
W.R. Berkley Corp
Connecticut
$453K -$2.06M -188,848 -82%
NM
9
Newtyn Management
New York
$437K +$440K +40,333 New
Verition Fund Management
10
Verition Fund Management
Connecticut
$325K +$328K +30,000 New
Jane Street
11
Jane Street
New York
$298K +$301K +27,558 New
SSA
12
Schonfeld Strategic Advisors
New York
$178K +$180K +16,481 New
PTC
13
Philadelphia Trust Company
Pennsylvania
$162K +$164K +15,000 New
DTL
14
Dynamic Technology Lab
Singapore
$130K -$86.9K -7,959 -40%
FHC
15
First Heartland Consultants
Missouri
$118K +$119K +10,925 New
WAM
16
Wolverine Asset Management
Illinois
$56K -$1.1M -101,156 -95%
Wells Fargo
17
Wells Fargo
California
$16K +$16.4K +1,500 New
Osaic Holdings
18
Osaic Holdings
Arizona
$11K +$10.9K +1,000 New
AWM
19
Avior Wealth Management
Nebraska
$10K +$10.9K +1,000 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$8K +$7.81K +715 New
Rockefeller Capital Management
21
Rockefeller Capital Management
New York
$5K +$5.46K +500 New
VFA
22
Valeo Financial Advisors
Indiana
$4K +$4.37K +400 New
Morgan Stanley
23
Morgan Stanley
New York
$3K +$2.73K +250 New
OP
24
Omni Partners
United Kingdom
– -$11M -1,080,090 Closed
BFM
25
Boothbay Fund Management
New York
– -$6.2M -609,980 Closed
1
2

HUMA Hedge Fund Activity: Q1 2021 in Review

23 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q1 2021, worth a combined $26.2M — down 42% from $44.7M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new HUMA positions and 17 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Alpine Global Management, opening a new position worth an estimated $5.69M. The largest seller was Omni Partners, exiting entirely with an estimated $11M sold.

  • 23 institutional investors held Humacyte (HUMA) as of Q1 2021, up from 21 in Q4 2020.
  • Funds reported $26.2M of Humacyte stock for Q1 2021, down 42% quarter-over-quarter.
  • 19 funds opened new Humacyte positions in Q1 2021 and 17 closed out, a net change of +2 holders.
  • The largest Humacyte buyer in Q1 2021 was Alpine Global Management, an estimated $5.69M added.
  • The largest Humacyte seller in Q1 2021 was Omni Partners, an estimated $11M sold.

Based on aggregated 13F filings for Q1 2021.